Campaign launched to eradicate malaria

Shutterstock
Basel - Novartis and Malaria No More have announced the debut of the Power of One (http://www.Po1.org) campaign, encouraging people worldwide to help end child deaths from malaria.

Novartis will support the campaign financially and donate up to three million Coartem® Dispersible treatments to match antimalarials funded by the public.

The company’s commitment aligns with its long history in the fight against malaria and the Novartis malaria initiative is one of the largest access-to-medicine programmes in the healthcare industry.

Malaria is a preventable and treatable disease, but it still kills a child every minute.

It is estimated over 300 million additional treatments will be needed to treat malaria patients across Africa between now and the end of 2015.

The Power of One campaign aims to address the treatment gap through direct donations and existing government commitments.

Every dollar donated to the campaign will buy and deliver a treatment to a child diagnosed with malaria. 

Networks

The CEO of Novartis, Joseph Jimenez, said: “I'm proud of the significant and longstanding commitment Novartis has to the fight against malaria.

"For all our progress though, there’s still more work to do and we need more help to close the treatment gap.

"The Power of One offers everyone a chance to engage and make a difference for children suffering from malaria.”

Harnessing social, mobile, and e-commerce technologies, Power of One enables the public to purchase a treatment and track its journey.

Donors will be able to see the effect of their donation on the ground, share information with their networks and recruit other donors.

“It’s unacceptable that a child dies every minute for lack of a dollar’s worth of treatment,” said Martin Edlund, CEO, Malaria No More.

“We’re urging the world to join the Power of One campaign and to donate and engage their friends in this fight.”

Children


Novartis is the exclusive treatment sponsor of the Power of One campaign, joining some of the world’s most innovative companies.

Additional sponsors include Alere, which will provide malaria rapid diagnostic tests, as well as 21st Century Fox, AHAlife.com, Causes.com, Time Warner, Twitter, Venmo and others.

Zambia will be the first country to receive deliveries of treatments and tests as a result of the Power of One campaign.

Since 2009, Novartis has delivered 200 million treatments of its paediatric antimalarial Coartem® Dispersible without profit to more than 50 malaria-endemic countries.

Never before have so many paediatric treatments been distributed in such a short timeframe for children suffering from malaria.

The 200 millionth treatment was delivered to Zambia, which also received the first consignment of Novartis treatments for the Power of One campaign, raised during World Malaria Day on 25 April this year.

For more information: http://www.malaria.novartis.com

Photo:  Mosquito from Shutterstock

For Novartis multimedia content, please visit http://www.thenewsmarket.com/Novartis

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 348 votes
I foresee a second term for Cyril Ramaphosa
82% - 4359 votes
Don’t discount a Zweli Mkhize win
12% - 620 votes
Vote
Rand - Dollar
18.09
-0.8%
Rand - Pound
20.21
-0.2%
Rand - Euro
17.74
-0.1%
Rand - Aus dollar
11.59
-0.3%
Rand - Yen
0.13
-0.1%
Gold
1,660.90
0.0%
Silver
19.03
0.0%
Palladium
2,166.50
0.0%
Platinum
864.50
0.0%
Brent Crude
85.14
-2.4%
Top 40
57,390
+0.8%
All Share
63,726
+0.7%
Resource 10
60,230
+0.7%
Industrial 25
77,400
+0.8%
Financial 15
13,796
+0.7%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE